Microbe–Host Interactions in Human Infections
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 1539
Special Issue Editors
Interests: Aspergillus ssp.; Candida spp.; fungal infections; antimycotic drugs; fungal biofilm; fungi-host interaction; antifungal resistance; natural compounds
Special Issues, Collections and Topics in MDPI journals
Interests: Candida; Aspergillus; retinoids; trifarotene; all-trans retinoic acid; Trichophyton; psoriasis; mycobiota; botulin toxin; IL-17; apremilast; bimekizumab; poliomavirus; glutathione
Special Issue Information
Dear Colleagues,
Despite the huge progress which has been made in recent decades, infectious diseases continue to pose a serious threat to public health. The global rise in antimicrobial resistance in pathogens, in the era of new emerging and re-emerging zoonotic infectious diseases, has challenged the medical community.
Microbial infection is a highly dynamic process between the host immunity and microbes. Although important advances have been made in understanding the complex interplay between the host and pathogens during infection, our knowledge of these processes is still limited.
Deciphering the mechanisms by which microbes cause disease in a susceptible host is crucial for the identification of new potential drug targets in pathogens and the development of novel prophylactic and/or therapeutic measures against infections.
On the other hand, a comprehensive elucidation of the innate and adaptive immune responses to microbial infections may lead to the development of host-directed immunotherapies, aimed at enhancing the host immunity or modulating excessive hyperinflammatory responses to pathogens, with the additional benefit of preventing or limiting the development of antimicrobial resistance.
This Special Issue aims to promote knowledge in the field of microbe–host interactions, paying particular attention to the mechanisms of microbial pathogenicity, identification of new drug targets in pathogens, and immune response characterization in human infections.
Dr. Roberta Gaziano
Dr. Terenzio Cosio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microbe–host interactions
- microbial pathogenesis
- virulence factors
- microbial drug targets
- host immune response
- immunotherapies
